CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, CVS Health is rated Zacks Rank #5 (Strong Sell). The chart below shows the ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

CVS Health Corp (CVS) stock saw a decline, ending the day at $51.96 which represents a decrease of $-0.18 or -0.35% from the prior close of $52.14. The stock opened at $51.43 and touched a low of $50.

CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

CVS and its top executives succeeded Tuesday in convincing Rhode Island’s top court to affirm the dismissal of allegations ...

CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...